Monoclonal antibody therapy of T cell lymphoma: single agent trials of anti-CD2 (Siplizumab) and anti-CD4 (Humax-CD4). Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 3, n. 1, 2009. DOI: 10.4081/hmr.v3i1.532. Disponível em: https://journals.pagepress.org/hmr/article/view/532. Acesso em: 20 jun. 2025.